/PRNewswire/ Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions to drive better patient.
/PRNewswire/ Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the.
BOSTON, Feb. 27, 2023 /PRNewswire/ Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 44th Annual Institutional Investors Conference on Monda.
/PRNewswire/ Haemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal 2023, which ended December 31, 2022, are.
/PRNewswire/ Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2023 financial results at 6:00 am.